NYU Langone's Perlmutter Cancer Center

New York, New York 10016

2 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Bladder Cancer, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• Blue Light Cystoscopy With Cysview® Registry — Recruiting now